粘合剂作为创伤中的栓塞剂的使用
Kimberly Coffman1, Arthur Joseph1, John A Walker1
1Department of Radiology, University of Texas Health San Antonio, San Antonio, Texas.
Seminars in interventional radiology
|November 14, 2025
概括
在稳定的患者中,N-butanyl 2-cyanoacrylate (NBCA) 是一种安全有效的选择,用于管理创伤性出血. 了解其应用和技术至关重要,以尽量减少栓塞过程中的潜在并发症.
科学领域:
- 干预性放射学 干预性放射学
- 创伤外科 手术 创伤外科
- 血管栓塞是因为血管栓塞.
背景情况:
- 非手术治疗越来越多地用于血液动力学稳定的患有出血性创伤伤害的患者.
- N-丁-2-烯酸 (NBCA) 已成为各种创伤性出血的可行的栓塞剂.
研究的目的:
- 审查NBCA在创伤伤害管理中的应用.
- 要突出使用NBCA的作用机制,好处,缺点和技术.
- 强调正确技术的重要性,以避免并发症.
主要方法:
- 关于创伤中的NBCA栓塞的文献综述.
- 讨论NBCA在固体器官损伤,骨盆骨折和深度/表面创伤中的非标签用途.
- 分析潜在的并发症和预防措施.
主要成果:
- 在固体器官损伤,骨盆骨折和其他创伤性出血中,NBCA粘合剂有效用于栓塞.
- 它可以单独使用,也可以与诸如微线圈之类的附件一起使用.
- 对技术的正确理解对于成功的结果至关重要.
结论:
- NBCA是一种安全有效的栓塞剂,用于血液动力学稳定的患者的特定创伤性出血.
- 操作人员对NBCA的性能和应用技术的了解对于安全有效的使用至关重要.
- 坚持适当的技术可以减轻风险,如非目标栓塞和导管封闭.
更多相关视频
相关概念视频
01:05Introduction to Hemostasis
13.2K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
13.2K
01:22Formation of the Platelet Plug
8.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.6K
01:16Clot Retraction and Fibrinolysis
8.3K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.3K
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
293
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
293
01:20Extrinsic and Intrinsic Pathways of Hemostasis
11.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.9K